Risk of perioperative discontinuation of SGLT2 inhibitors
Maartina J P Oosterom-Eijmael, Jeroen Hermanides, Daniël H. van Raalte, Abraham H. Hulst
Topics & Concepts
MedicineDiscontinuationEmpagliflozinDiabetic ketoacidosisHeart failureIntensive care medicinePerioperativeDiabetes mellitusKetoacidosisHyperkalemiaDapagliflozinInternal medicineSurgeryType 2 Diabetes MellitusEndocrinologyType 1 diabetesDiabetes Treatment and ManagementHyperglycemia and glycemic control in critically ill and hospitalized patientsBariatric Surgery and Outcomes